Allergic rhinitis requires a combination of history, nasal endoscopy, nasal smear, allergen skin test results, and serum specific IgE titers to confirm the diagnosis. The only promising treatment for allergic rhinitis is desensitization therapy, but not all patients are suitable for desensitization therapy. Desensitization is suitable for children over 5 years of age and adults who have only one allergen. Desensitization treatment is available as subcutaneous injections and sublingual administration. The course of treatment takes three years. The cure rate reported varies from 50-80%. If desensitization is not possible, only medication can be used. The aim of treatment is to reduce the impact of symptoms on life and work. Combined medication is recommended: 1. Nasal spray hormone: budesonide nasal spray, or fluticasone propionate nasal spray, or mometasone furoate nasal spray. The course of treatment for one month. 2. Topical antihistamines: nasal spray of azelastine hydrochloride. The course of treatment is two weeks. 3.Oral antihistamines: loratadine. The course of treatment is six days. 4.Oral leukotriene antagonist: montelukast sodium. Duration of treatment: 15 days. Patients who have been diagnosed with allergic rhinitis by history, nasal endoscopy, allergen skin test, and serum specific IgE titer may be considered for surgery only in the following scenarios (but the goal of surgery is only to relieve symptoms and not to cure allergic rhinitis): 1. tipped polyps in the upper and middle nasal passages 2. severe deviation of the upper anterior nasal septum 3. significant thickening of the mucosa of the sinuses in the whole group of sinus CT